The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins

AbstractPurpose. The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-β-cyclodextrin, HP-β-CD) and anionically charged (SBE7-β-CD) modified β-cyclodextrins. SBE7-β-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of β-cyclodextrin. The number seven refers to the average degree of substitution. Methods. The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25°C as a function of pH and cyclodextrin concentration by the phase-solubility method. Results. Except for miconazole and cinnarizine (AP-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-β-CD and SBE7-β-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-β-CD than with HP-β-CD. For the anionic agents, the binding constants between SBE7-β-CD and HP-β-CD were similar while the binding constants for the cationic agents with SBE7-β-CD were superior to those of HP-β-CD, especially when compared with the neutral form of the same drug. Conclusions. A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-β-CD.

[1]  K. A. Connors,et al.  Effect of cycloamyloses on apparent dissociation constants of carboxylic acids and phenols: equilibrium analytical selectivity induced by complex formation. , 1976, Journal of pharmaceutical sciences.

[2]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[3]  V. Stella,et al.  The effect of SBE4-β-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: Comparison to a co-solvent solution and a water-soluble prodrug , 1995 .

[4]  V. Stella,et al.  Differential Effects of Sulfate and Sulfobutyl Ether of β-Cyclodextrin on Erythrocyte Membranes in Vitro , 2004, Pharmaceutical Research.

[5]  Valentino J. Stella,et al.  β‐Cyclodextrin Derivatives, SBE4‐β‐CD and HP–β‐CD, Increase the Oral Bioavailability of Cinnarizine in Beagle Dogs , 1995 .

[6]  D. Duchěne,et al.  Indomethacin and cyclodextrin complexes , 1991 .

[7]  A. Urtti,et al.  Sulfobutyl ether β-cyclodextrin (SBE-β-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits , 1995 .

[8]  B. Müller,et al.  Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives , 1991 .

[9]  D Wouessidjewe,et al.  High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex. , 1990, Journal of pharmaceutical sciences.

[10]  T. Nagai,et al.  Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state. , 1984, Chemical & pharmaceutical bulletin.

[11]  K. A. Connors,et al.  Potentiometric study of molecular complexes of weak acids and bases applied to complexes of alpha-cyclodextrin with para-substituted benzoic acids. , 1982, Journal of pharmaceutical sciences.

[12]  D. Bindra,et al.  Effect of SBE4-β-CD, a sulfobutyl ether β-cyclodextrin, on the stability and solubility of O6-benzylguanine (NSC-637037) in aqueous solutions , 1995 .

[13]  B. D. Anderson,et al.  Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins. , 1994, Journal of pharmaceutical sciences.

[14]  K. A. Connors,et al.  trans-Cinnamic acid--alpha-cyclodextrin system as studied by solubility, spectral, and potentiometric techniques. , 1980, Journal of pharmaceutical sciences.

[15]  A. Scarpellini,et al.  Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole , 1993 .

[16]  V. Stella,et al.  Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. , 1995, Journal of pharmaceutical sciences.

[17]  N. Bodor,et al.  The potential use of cyclodextrins in parenteral formulations. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[18]  M A Mintun,et al.  Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions. , 1981, Journal of pharmaceutical sciences.

[19]  S. Pedersen,et al.  Polymorphism of miconazole during preparation of solid systems of the drug and β-cyclodextrins , 1993 .

[20]  Valentino J. Stella,et al.  The effect of SBE4-β-CD on i.v. methylprednisolone pharmacokinetics in rats: Comparison to a co-solvent solution and two water-soluble prodrugs , 1995 .

[21]  V. Stella,et al.  The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. , 1994, Current eye research.

[22]  V. Stella,et al.  Characterization of sulphoalkyl ether derivatives of beta-cyclodextrin by capillary electrophoresis with indirect UV detection. , 1992, Journal of pharmaceutical and biomedical analysis.

[23]  J. Pitha Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients. , 1985, Journal of pharmaceutical sciences.

[24]  Kap Lim,et al.  Solubilization of Thiazolobenzimidazole Using a Combination of pH Adjustment and Complexation with 2-Hydroxypropyl-β-Cyclodextrin , 1993, Pharmaceutical Research.

[25]  A. Mitra,et al.  Cyclodextrin/Weak-Electrolyte Complexation: Interpretation and Estimation of Association Constants from Phase Solubility Diagrams , 1992, Pharmaceutical Research.